Department of Nephrology, Hiroshima University Hospital

 
Publication list

The files below provide information on our research results, including recent dissertations and research activity reports,

2017

CEN Case Rep. (in press)
Diffuse Large B-cell Lymphoma Presenting as Bilateral Renal Infiltration Leading to Acute Kidney Injury
Okubo T, Hirashio S, Shimizu M, Kuroda Y, Doi S, Masaki T.
PLoS One. 12: e0178967, 2017
Seasonal variation in hemodialysis initiation: A single-center retrospective analysis.
Maeoka Y, Naito T, Irifuku T, Shimizu Y, Ogawa T, Masaki T.
Kidney Int Rep. (in press)
A case of fibronectin glomerulopathy caused by missense mutations in the fibronectin 1 gene.
Hirashio S, Yamada Y, Mandai K, Hara S, Masaki T.
PLoS One. 12: e0173706, 2017
Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.
Maeda K, Doi S, Nakashima A, Nagai T, Irifuku T, Ueno T, Masaki T.
Contrib Nephrol. 189:178-183, 2017
Klotho as a Therapeutic Target during the Development of Renal Fibrosis.
Doi S, Masaki T.

2016

Clin Exp Nephrol. (in press)
Valproic acid attenuates renal fibrosis through the induction of autophagy.
Kawaoka K, Doi S, Nakashima A, Yamada K, Ueno T, Doi T, Masaki T.
Nephrology (Carlton). (in press)
Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal FGF23 levels of maintenance hemodialysis patients.
Yamashita K, Mizuiri S, Nishizawa Y, Kenichiro S, Doi S, Masaki T.
PLoS One. 11:e0160993, 2016
Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice.
Nagai T, Doi S, Nakashima A, Irifuku T, Sasaki K, Ueno T, Masaki T.
Hemodial Int. 20: 580-588, 2016
Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
Ago R, Shindo T, Banshodani M, Shintaku S, Moriishi M, Masaki T, Kawanishi H.
Kidney Int. 89: 147-157, 2016
Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
Irifuku T, Doi S, Sasaki K, Doi T, Nakashima A, Ueno T, Yamada K, Arihiro K, Kohno N, Masaki T.
J Am Soc Nephrol. 27: 203-215, 2016
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.
Sasaki K, Doi S, Nakashima A, Irifuku T, Yamada K, Kokoroishi K, Ueno T, Doi T, Hida E, Arihiro K, Kohno N, Masaki T.
Clin Exp Nephrol. 20: 30-38, 2016
High glucose promotes TGF-β1 production by inducing FOS expression in human peritoneal mesothelial cells.
Kokoroishi K, Nakashima A, Doi S, Ueno T, Doi T, Yokoyama Y, Honda K, Kanawa M, Kato Y, Kohno N, Masaki T.

2015

J Vasc Access. 16: S58-61, 2015
Vascular access intervention by a nephrologist in Hiroshima.
Doi S, Masaki T.
Clin Exp Nephrol. 19: 631-638, 2015
Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study.
Soji K, Doi S, Nakashima A, Sasaki K, Kawai T, Aoki A, Kyuden Y, Fujiwara K, Yokoyama Y, Masaki T.
Intern Med. 54: 887-894, 2015
The serum lipids levels may be underestimated in patients on hemodialysis.
Ueno T, Doi S, Nakashima A, Yokoyama Y, Doi T, Kawai T, Kusano Y, Ueda C, Masaki T.
Ther Apher Dial. 19: 245-249, 2015
Hemodialysis immediately after cardiac catheterization is a risk factor for intradialytic hypotension.
Irifuku T, Naito T, Ogawa T, Shimizu Y, Maeoka Y, Masaki T.
Clin Exp Nephrol. 19: 830-837, 2015
Expression of age-related factors during the development of renal damage in patients with IgA nephropathy.
Yamada K, Doi S, Nakashima A, Kawaoka K, Ueno T, Doi T, Yokoyama Y, Arihiro K, Kohno N, Masaki T.

2014

Clin Exp Nephrol. 18: 189-193, 2014
Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency.
Hirashio S, Ueno T, Naito T, Masaki T.
Clin Nephrol. 82: 268-272, 2014
Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome.
Irifuku T, Naito T, Ogawa T, Masaki T.
Clin J Am Soc Nephrol. 9: 2117-2122, 2014
Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients.
Hirashio S, Nakashima A, Doi S, Anno K, Aoki E, Shimamoto A, Yorioka N, Kohno N, Masaki T, Tahara H.
PLoS One. 9: e93513, 2014
Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats.
Doi T, Doi S, Nakashima A, Ueno T, Yokoyama Y, Kohno N, Masaki T.
Clin Exp Nephrol. 18: 499-506, 2014
Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis.
Shiraki N, Nakashima A, Doi S, Carrero JJ, Sugiya N, Ueno T, Stenvinkel P, Kohno N, Masaki T.

2013

Kidney Int. 84: 297-307, 2013
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, Doi T, Higashi Y, Yorioka N, Kato Y, Kohno N, Masaki T.

2012

Clin Exp Nephrol. 16: 921-929, 2012
Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients.
Ago R, Nakashima A, Naito T, Doi S, Ochiai M, Hamaguchi N, Yokoyama Y, Tanaka J, Yorioka N, Masaki T, Kohno N.
CEN Case Rep. 1: 24-28, 2012.
A case of renal hypouricemia and a G774A gene mutation causing acute renal injury that was improved by hemodialysis.
Hirashio S, Yamada K, Naito T, Masaki T.

pageup